Chiara Simone
Milan, 20122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS.
Journal: Scientific reports
Published: February 05, 2016
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype.
Journal: Scientific reports
Published: October 09, 2015
Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?
Journal: Cellular and molecular life sciences : CMLS
Published: May 29, 2015
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches.
Journal: Scientific reports
Published: March 18, 2015
MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives.
Journal: Journal of the neurological sciences
Published: December 17, 2014
Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives.
Journal: Stem cell research & therapy
Published: August 27, 2014
Therapeutic development in amyotrophic lateral sclerosis.
Journal: Clinical therapeutics
Published: July 18, 2014
Pluripotent stem cell-based models of spinal muscular atrophy.
Journal: Molecular and cellular neurosciences
Published: May 27, 2014
The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review.
Journal: Journal of the neurological sciences
Published: May 07, 2014
iPSC-Derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1.
Journal: Stem cell reports
Published: February 09, 2014
Last Updated: 09/26/2026